GE

Gevo, Inc.

GEVOBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$160.6M
+849.3% YoY
Net Income
-$33.8M
+57.0% YoY
EBITDA
$12.3M
+121.7% YoY
Free Cash Flow
$18.5M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 28 MACD Positive CrossoverHistogram +0.0114, positive momentum
Aug 27 MACD Positive CrossoverHistogram +0.0078, positive momentum
About Gevo, Inc.

Headquartered within the basic materials sector, Gevo, Inc. focuses on Specialty Chemicals services and products. Gevo, Inc. operates as a carbon abatement company. Valued at $407.9M, GEVO is a small-cap name in its sector. It operates in four segments: Gevo, GevoFuels, GevoRNG, and GevoND.

Where GEVO stands vs its 150-day and 200-day moving averages

As of the August 28, 2026 close, GEVO finished 7.18% below its 150-day moving average ($1.81) and 10.64% below its 200-day moving average ($1.88). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is GEVO overbought or oversold?

At the August 28, 2026 close, GEVO's RSI(14) was 58.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$407.9M
Fwd P/E27.50
EPS$-0.89
Beta1.05
52W Change+1.2%
ROE-55.5%
Analysis

On the balance sheet, GEVO has $58.1M in cash with $170.7M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $18.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -55.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $1.2M (2022) to $160.6M (2025), reflecting a 13566% increase over the period.

Investors considering Gevo, Inc. should weigh the typical risks associated with GEVO's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Gevo, Inc.'s trajectory.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms